Substituted 1,2,3,4-tetrahydroisoquinoline derivatives

Details for Australian Patent Application No. 2005250077 (hide)

Owner Actelion Pharmaceuticals Ltd.

Inventors Koberstein, Ralf; Fischli, Walter; Clozel, Martine; Aissaoui, Hamed; Weller, Thomas

Agent A J Park

Pub. Number AU-B-2005250077

PCT Pub. Number WO2005/118548

Priority PCT/ EP2004/002020 01.03.04 EP

Filing date 23 February 2005

Wipo publication date 15 December 2005

Acceptance publication date 9 June 2011

International Classifications

C07D 217/18 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/118548 Priority application(s): WO2005/118548

9 June 2011 Application Accepted

  Published as AU-B-2005250077

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250081-Tapping tube

2005250074-Metabolically engineered cells for the production of polyunsaturated fatty acids